Chimeric antigen receptor T-cell therapy for high-grade B-cell lymphoma NOS.
Saved in:
| Title: | Chimeric antigen receptor T-cell therapy for high-grade B-cell lymphoma NOS. |
|---|---|
| Authors: | Hossain NM; Division of Hematology/Oncology-Cell Therapy and Transplant Program, University of Pennsylvania-Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Ahn KW; Division of Biostatistics, Institute for Health and Society, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Patel J; CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Lian Q; CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Bilal Abid M; The University of Texas Health Science Center at Houston (UTHealth Houston), Houston, Texas, USA., Al Nughmush A; Department of Hematology, Stem Cell Transplant and Cellular Therapy, Oncology Centre, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia., Bacher U; Department of Hematology, Inselspital, University Hospital and University of Bern, Bern, Switzerland., Bi X; Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Hashmi SK; Mayo Clinic, Rochester, Minnesota, USA.; SSMC, Abu Dhabi, UAE., Hilal T; Mayo Clinic, Phoenix, Arizona, USA., Husnain M; Division of Hematology/Oncology, Banner University of Arizona, Medical Center, Tucson, Arizona, USA., Khimani F; Moffitt Cancer Center, Tampa, Florida, USA., Maziarz RT; Knight Cancer Institute-Oregon Health and Science University, Portland, Oregon, USA., Modi D; Karmanos Cancer Institute, Wayne State University, Detroit, Michigan, USA., Ram R; Hematology Department-Tel Aviv (Sourasky) Medical Center, Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv-Yafo, Israel., Rizzieri D; Novant Health Cancer Institute, Charlotte, North Carolina, USA., Sica RA; Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York, USA., Steinberg A; New York Medical College, Valhalla, New York, USA., Vij R; Division of Medical Oncology, Washington University in St Louis, St. Louis, Missouri, USA., Shadman M; University of Washington, Seattle, Washington, USA., Turtle C; University of Sydney School of Medicine, Sydney, New South Wales, Australia.; Royal North Shore Hospital, Sydney, New South Wales, Australia., Hamadani M; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Herrera AF; City of Hope National Medical Center, Duarte, California, USA. |
| Source: | British journal of haematology [Br J Haematol] 2025 Sep; Vol. 207 (3), pp. 1011-1018. Date of Electronic Publication: 2025 Jul 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
